메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition

AVONDALE, Pa., Dec. 2, 2025 -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its patient positioning and marking product portfolio. The acquisition reinforces CQ Medical's mission to advance precision in radiotherapy, empowering clinicians and improving outcomes worldwide. Bionix has established a strong reputation of developing innovative, high-quality medical devices across multiple patient care segments for over 40 years. Following
- 김갑성 기자
- 2025-12-02 02:07
United Imaging Broadens Imaging Portfolio and Advances Native AI at RSNA 2025

[ 메디채널 김갑성 기자 ] The company brings a full array of technology to its two booths in Chicago, showcasing another year of increasing R&D and investment. CHICAGO, Dec. 2, 2025 -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2025. Under the theme "Passion for Change, For One and All," the company will highlight how its technology is built to see the uniqueness of each individual and extend access to advanced care across different communities. The portfolio on d
- 김갑성 기자
- 2025-12-02 00:00
The Frost & Sullivan Institute Honors Global Organizations Pioneering Responsible Growth With the 2025 Visionary Growth Leadership Best Practices Recognition

SANTA CLARA, Calif., Dec. 1, 2025 -- The Frost & Sullivan Institute is proud to announce the recipients of the 2025 Visionary Growth Leadership Best Practices Recognition, celebrating organizations that exemplify purpose-driven innovation, sustainable business models, and leadership committed to creating a positive global impact. This recognition highlights the companies that are spearheading meaningful change and addressing the global priorities identified by the Frost & Sullivan Institute. "The Visionary Growth Leadership Best Practices Recognition celebrates companies t
- 김갑성 기자
- 2025-12-01 22:40
UNICEF and Rönesans Partner to Transform Youth Vocational Education in Türkiye

ISTANBUL, Dec. 1, 2025 -- Rönesans Holding, has announced its role as a major private sector partner in UNICEF's "From Learning to Earning for Youth" programme. In collaboration with the Ministry of National Education, this bold initiative is set to reimagine vocational education for young people across Türkiye, equipping the next generation with the skills they need to thrive. Bridging Ambition and Opportunity As a pioneering partner of the initiative, Rönesans Holding will open the doors of Gaziantep City Hospital - one of Türkiye'
- 황정호 기자
- 2025-12-01 21:02
KPJ Healthcare launches first Centre of Excellence at Johor Specialist Hospital, advancing KPJ Health System in collaboration with Mayo Clinic Global Consulting

JOHOR BAHRU, Malaysia, Dec. 1, 2025 -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Centre of Excellence ("CoE") under the KPJ Health System ("KPJHS"), marking a decisive step in the Group's transformation into an integrated academic health system. The inaugural Heart & Lung CoE is established at Johor Specialist Hospital ("JSH") and will anchor a unified service line across KPJ's network through standardised clinical pathways, multidisciplinary reviews and data-driven improvement. Introd
- 김갑성 기자
- 2025-12-01 20:49
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the promise of programmable biology SOMERVILLE, Mass., Dec. 1, 2025 -- Generate:Biomedicines ("Generate") today announced it plans to initiate two global Phase 3 clinical trials, SOLAIRIA-1 and SOLAIRIA-2, evaluating GB-0895 in approximately 1,600 adults and adolescents with se
- 김갑성 기자
- 2025-12-01 19:00
제너레이트 바이오메디슨, AI 설계 장기 지속형 항-TSLP 항체 'GB-0895' 글로벌 3상 시험 착수

SOLAIRIA-1 및 SOLAIRIA-2 시험, 기존 요법으로 여전히 적절하게 조절되지 않는 중증 천식 환자 약 1600명 대상 GB-0895 평가 장기 지속형 항-TSLP 항체에 대한 최초의 글로벌 3상 시험...GB-0895, '프로그래머블 바이올로지'의 잠재력을 입증하며 중요한 진전 이뤄 서머빌, 매사추세츠, 2025년 12월 1일 -- 제너레이트 바이오메디슨(Generate:Biomedicines, 이하 '제너레이트')가 12월 1일 기존 요법에도 불구하고 여전히 적절하게 조절되지 않는 성인 및 청소년 중증 천식 환자 약 1600명을 대상으로 GB-0895를 평가하는 두 건의 글로벌 3상 임상시험(SOLAIRIA-1, SOLAIRIA-2)을 개시할 계획이라고 밝혔다. GB-0895는 AI로 설계된 장기 지속형 임상시험용 단일클론 항체로, 기도 염증을 유발하는 핵심 인자인 흉선 스트로마 림포포이에틴(TSLP)을 표적한다. 두 시험의 일차 목적은 52주 동안의 임상적으로 의미 있는 천식 악화 감소에 대한 GB-0895의 유효성을 평가하는 것이다. GB-0895는 AI를 활용해 초고친화도 TSLP 결합
- 김갑성 기자
- 2025-12-01 19:00
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po

HONG KONG, Dec. 1, 2025 -- Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court in Tai Po, which caused multiple casualties and left many residents homeless and in urgent need of assistance. The Group has made a donation of HK$200,000 to the "Support Fund for Wang Fuk Court in Tai Po" established by the HKSAR Government to render assistance to residents of Wang Fuk Court and support all relevant works. As a pharmaceutical company listed
- 김갑성 기자
- 2025-12-01 18:46
CooperVision Opens Regional Service Centre in partnership with CEVA Logistics to Accelerate Asia Pacific Growth.

Driving faster delivery and broader portfolio access across the region. SINGAPORE, Dec. 1, 2025 -- CooperVision Asia Pacific, in collaboration with CEVA Logistics, has opened a new Regional Service Centre in Singapore, marking a significant milestone in both companies' commitment to enhance supply chain and logistics capabilities across the Asia Pacific region. Strategically located in CEVA's healthcare hub facility within Singapore's Airport Logistics Park, a designated free trade zone adjacent to Changi Airport, the centre marks the first phase of a broader in
- 김갑성 기자
- 2025-12-01 17:10
Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool

Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster "time to actionable insight" of outbreaks, from detection to control measures being in place. SINGAPORE, Dec. 1, 2025 -- Asia Pathogen Genomics Initiative (Asia PGI) today offered the first public preview of PathGen, an AI-powered sense-making and decision-making support platform of pathogen genomics and contextual data. Designed for public health practitioners, clinicians and industry, it can help detect e
- 김갑성 기자
- 2025-12-01 17:10

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-12-19_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 19일 17시 00분